Drug Trial Radar · NCT01897987
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
Last checked: Nov 20, 2026Latest source record: Aug 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Jan 2014
Primary completion
Mar 2020
Study completion Mar 2020
Sponsor
- Lead sponsor
- Medipost Co Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 12, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 7 months, up to 7 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a follow-up study to investigate the long-term safety and efficacy of PNEUMOSTEM® versus placebo, for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the Phase II trial (NCT01828957) will be followed-up until 60 months of corrected age.
Conditions
- Bronchopulmonary Dysplasia
Interventions
Pneumostem®Biological
normal salineBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Respiratory outcome: readmission rate and duration of the hospital stay due to respiratory infectionTime frame: 6, 12, 18, 24, 36, 48, and 60 months, corrected age
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.